XFOR X4 Pharmaceuticals, Inc

NEUTRAL Impact: 2/10 Institutional Cluster
Horizon weeks Processed 3d 22h ago
Institutional cluster: 2 buyers, 3 sellers (mixed)

Executive Summary

An institutional cluster in X4 Pharmaceuticals shows mixed conviction in Q3 2025, with two mega-passive buyers (Vanguard and State Street) adding small positions aggregating $1.1M while three mega-passive sellers (BlackRock, BofA, Morgan Stanley) trimmed a net of -$223K. The cluster is dominated entirely by passive index rebalancing funds, not active managers, and the absolute dollar amounts are trivial relative to the $352M market cap — generating no actionable signal for traders.

Key Financial Metrics

Direction
mixed
Buy Value
$1.5M
Sell Value
$514.0K
Net Flow
$877.0K

Institutional Positions

Net institutional flow: $877.0K

▲ Buyers (2)

InstitutionActionChangePosition ValueValue Δ
Vanguard ADD +77% $1.4M $963.0K
State Street DOUBLED +149.3% $132.0K $103.0K

▼ Sellers (3)

InstitutionActionChangePrev ValueValue Δ
BlackRock TRIM -65.4% $341.0K -$128.7K
BofA NEAR_EXIT -76% $153.0K -$86.6K
Morgan Stanley TRIM -65.9% $21.0K -$8.0K

Actionable Insight

This cluster reflects index-tracking rebalancing noise, not informed directional conviction. With 89% of analysts bullish but no active-manager participation in the cluster, traders should disregard this 13F signal entirely and monitor upcoming quarterly operating results or pipeline catalysts for price direction. The historically poor T+5 returns on prior neutral calls (-1.91% avg) further caution against trading on this data.

Key Facts

  • Aggregate buyers: Vanguard ADD +77% ($963K added), State Street DOUBLED +149% ($103K added)
  • Aggregate sellers: BlackRock TRIM -65.4% (-$129K), BofA NEAR_EXIT -76% (-$87K), Morgan Stanley TRIM -65.9% (-$8K)
  • All five institutions are mega-passive index fund managers — no active hedge funds or family offices participate
  • Net aggregate dollar flow is only ~$1.1M buyer-side vs -$0.2M seller-side, or <0.4% of market cap
  • 13F filing lag (45+ days) means these positions may have already been unwound

Financial Impact

Two passive buyers added $1.1M in new exposure while three passive sellers reduced holdings by $0.22M — combined net ~$0.9M of institutional flow, negligible relative to $352M market cap

institutional holdingspassive fund rebalancing

Risk Factors

  • 13F positions are stale (45-day reporting lag) and may have been reversed
  • All participants are passive/index funds — actions driven by portfolio weights, not fundamental views
  • Absolute dollar amounts are immaterial — 0.3% of float at most

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
89% bullish (9 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-XFOR-2025-Q3
8 reports for XFOR
Performance horizon
Filters
Rows
Reports for XFOR — sortable, filterable
Type Now
Jun 11, 2026
3d ago
Institutional Cluster
NEUTRAL ★ 2/10
$3.72 awaiting T+5awaiting T+5
Jun 11, 2026
3d ago
Institutional Cluster
NEUTRAL ★ 3/10
$3.72 awaiting T+5awaiting T+5
May 18, 2026
28d ago
EFFECT
NEUTRAL ★ 4/10
$3.68 $4.00▲ +8.70%▲ +7.08%
May 12, 2026
4w ago
144
NEUTRAL ★ 2/10
$4.23 $3.64▼ −13.95%▼ −12.79%
May 12, 2026
4w ago
8-K
NEUTRAL ★ 2/10
$4.23 $3.64▼ −13.95%▼ −12.79%
May 6, 2026
5w ago
Press Release
MIXED ★ 6/10
$4.38 $4.34▼ −0.91%▼ −2.04%
Mar 20, 2026
12w ago
DEFA14A
NEUTRAL ★ 2/10
$4.28 $4.04▼ −5.61%▼ −3.46%
Mar 17, 2026
12w ago
Press Release
MIXED ★ 6/10
$4.23 $3.82▼ −9.69%▼ −7.04%
Showing 8 of 8

US Market Status

Market Closed — Opens in 3h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access